MAGAR, S. D.; PAWAR, P. Y. In silico ADMET screening & molecular docking of some 1-(5-(4-chlorophenyl)-1,3,4-oxadiazol-3(2H)-yl) ethanone derivatives to be developed as triple mutant T790M/C797S EGFR inhibitors. International journal of health sciences, [S. l.], v. 6, n. S3, p. 10432–10451, 2022. DOI: 10.53730/ijhs.v6nS3.9448. Disponível em: https://sciencescholar.us/journal/index.php/ijhs/article/view/9448. Acesso em: 10 may. 2026.